Home
Journal Information
About
Aims and Scope
Contact Us
Editorial Board
Editor in Chief
Editorial Policies
Publication Ethics
Indexing/Abstracting
Peer review prosess
Publication Fee
Publisher
Editorial Board Policy
Human and Animal Rights
Journal Issues
Current Issue
In Press
All Issues
Guidelines
For Authors
For Reviewers
Call for Papers
Editorial Workflow
Implications
Informed Consent
Checklist for Review
Disclaimer
Conflicts of Interests
Create Account
Login
Please don't use dangerous characters
Title
Author
Abstract
Keywords
First Name
Last Name
Search
eISSN
:
2345-5004
J Herbmed Pharmacol
. 2024;13(1): 19-27. doi:
10.34172/jhp.2024.48132
Review
Berberine as a new neuraminidase inhibitor drug: A systematic review
Majid Asadi-Samani
1
, Dhiya Altememy
2
, Javad Saffari-Chaleshtor
3
, Mohammad-Taghi Moradi
4
*
Cited by CrossRef: 1
1- Gitto R, Lombardo L, Ravenda A, Broccolo F, Mastino A, De Luca L, Marino-Merlo F. Discovery of Influenza Neuraminidase Inhibitors: Structure-Based Virtual Screening and Biological Evaluation of Novel Chemotypes.
Molecules
. 2025;30(23):4636
[Crossref]
2- Bassetti M, Sepulcri C, Giacobbe D, Fusco L. Treating influenza with neuraminidase inhibitors: an update of the literature.
Expert Opinion on Pharmacotherapy
. 2024;25(9):1163
[Crossref]
Submit Your Paper
Editorial Board
Aims and Scope
Editorial Policies
Ethics
Contact Us
Archive